Neuphoria Therapeutics (NEUP) Enterprise Value (2022 - 2026)
Neuphoria Therapeutics' Enterprise Value was $524.87 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 39.7% from $870.88 million a year earlier but up 7.6% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Enterprise Value (2022 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Enterprise Value at Neuphoria Therapeutics came in at $521.5 million, down 39.7% from FY2025.
- Enterprise Value has now declined for four consecutive fiscal years, with a four-year compound annual growth rate of -51.5% (FY2022 to FY2026).
- In earlier fiscal years, Enterprise Value was $865.41 million in FY2025 (-23.2%), $1.13 billion in FY2024 (-65.4%), $3.26 billion in FY2023 (-65.5%) and $9.44 billion in FY2022.
- Quarterly Enterprise Value has moved between $423.24 million (fiscal Q2 2025) and $9.44 billion (fiscal Q4 2022) over five years.
- Compared with a year earlier, Enterprise Value was higher in two of the last eight quarters, with an average decline of 22.4%.
- The best year-over-year quarter for Enterprise Value over five years was fiscal Q1 2026 (growth of 124.4%); the worst was fiscal Q1 2025 (a decline of 83.9%).
- Per Business Quant data, NEUP's Enterprise Value in the three fiscal quarters before Q4 2026 was $487.93 million (Q3 2026), $461.49 million (Q2 2026) and $1.46 billion (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Neuphoria Therapeutics | 435.69 Mn | 360.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 524.87 Mn |
| Mar 31, 2026 | 487.93 Mn |
| Dec 31, 2025 | 461.49 Mn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 870.88 Mn |
| Mar 31, 2025 | 701.00 Mn |
| Dec 31, 2024 | 423.24 Mn |
| Sep 30, 2024 | 648.88 Mn |
| Jun 30, 2024 | 1.13 Bn |
| Mar 31, 2024 | 1.53 Bn |
| Dec 31, 2023 | 2.20 Bn |
| Sep 30, 2023 | 4.03 Bn |
| Jun 30, 2023 | 3.26 Bn |
| Jun 30, 2022 | 9.44 Bn |
API Access
Neuphoria Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();